Winners Announced at Medilink Healthcare Business Awards

Key Takeaways

• 300 delegates attended the awards at Sheffield’s Cutlers’ Hall.
• Medilink celebrated 30 years of fostering UK life‑science collaboration.
• Winners spanned startups, digital health, sustainability, and NHS partnerships.
• Sponsors included Equans Sci‑Tech, UKRI, B Braun, and regional health innovators.

Pulse Analysis

Medilink, the leading membership association for the UK life‑science sector, celebrated its 30th anniversary at the 2026 North of England Healthcare Business Awards. Based in Sheffield, the organisation has spent three decades linking biotech firms, medical‑device manufacturers, academic researchers and NHS trusts across the North, a region that now hosts a dense cluster of innovation hubs from Manchester to Leeds. By providing networking events, consultancy and market intelligence, Medilink has helped regional companies scale faster than many southern counterparts, positioning the North as a competitive alternative to the traditional London‑centric ecosystem.

The awards night highlighted a diverse set of winners that reflect current market priorities. Mitotype Precision Labs earned the Start‑up Award for its rapid‑turnaround genetic testing platform, while Open Medical was recognised for advances in digital healthcare, underscoring the surge in tele‑medicine and data‑driven patient monitoring. SANOFI’s NHS partnership and the Depuy Synthes‑Leeds collaboration demonstrated the growing importance of public‑private alliances, and Abingdon Health’s Sustainability Award signalled a sector‑wide shift toward greener manufacturing. Collectively, these accolades map the trajectory toward personalised, connected and environmentally responsible care.

For investors and policymakers, the ceremony offers a barometer of where capital is flowing. Sponsors such as Equans Sci‑Tech, UKRI and B Braun signal confidence in the region’s pipeline, while the presence of regional health innovation networks suggests coordinated funding strategies. The visibility afforded by the awards can accelerate deal‑making, attract talent and encourage further public‑sector support, reinforcing the North’s role in the UK’s broader health‑tech agenda. As the sector moves toward AI‑enabled diagnostics and sustainable production, Medilink’s platform will likely remain a catalyst for collaboration and growth.